Your browser doesn't support javascript.
loading
Incidence and predictors of COPD mortality in Uganda: A 2-year prospective cohort study.
Alupo, Patricia; Wosu, Adaeze C; Mahofa, Abdallah; Mugenyi, Levicatus; Semakula, Daniel; Katagira, Winceslaus; Kirenga, Bruce.
Afiliación
  • Alupo P; Makerere University Lung Institute, Makerere University College of Health Sciences, Kampala, Uganda.
  • Wosu AC; Makerere University Lung Institute, Makerere University College of Health Sciences, Kampala, Uganda.
  • Mahofa A; Department of Epidemiology, Johns Hopkins Bloomberg School of Public health, Baltimore, Maryland, United States of America.
  • Mugenyi L; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
  • Semakula D; Makerere University Lung Institute, Makerere University College of Health Sciences, Kampala, Uganda.
  • Katagira W; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
  • Kirenga B; Makerere University Lung Institute, Makerere University College of Health Sciences, Kampala, Uganda.
PLoS One ; 16(2): e0246850, 2021.
Article en En | MEDLINE | ID: mdl-33571315
ABSTRACT

BACKGROUND:

Data is lacking on outcomes among COPD patients in sub-Saharan Africa. The objective of the study was to assess the incidence and predictors of mortality among COPD patients enrolled in the Uganda Registry for Asthma and COPD. RESEARCH QUESTION What is the Incidence and predictors of mortality among COPD patients in Uganda? STUDY DESIGN AND

METHODS:

Individuals with a diagnosis of COPD at six hospitals in Uganda were enrolled into the registry, and followed every six months. Mortality was ascertained through post-mortem reports and verbal autopsies. Mortality rates (MR), mortality rate ratios (MRR), and hazard ratios (HR) were computed to assess associations between socio-demographic, behavioural, and clinical characteristics at enrolment into the registry and mortality up to two years after.

RESULTS:

We enrolled 296 COPD patients. Median age was 60 years, and 51·3% were male. The overall mortality rate was 95·90 deaths/1000 person-years. COPD severity by post-bronchodilator FEV1 was the strongest risk factor for mortality. Compared to stage 1, adjusted hazard ratios were as follows for stage 4 9·86 (95%CI 1·70-57·14, p = 0·011), stage 3 6·16 (95%CI 1·25-30·32, p = 0·025), and stage 2 1·76 (95%CI 0·33-9·48, p = 0·51). Underweight patients had a higher incidence of mortality compared to normal weight patients (MRR 3·47 (95%CI 1·45-8·31, p = 0·0026).

CONCLUSION:

Among COPD patients in Uganda, two-year mortality is high, and disease severity at baseline was the strongest risk factor for mortality. Our findings suggest the need for early, accurate, diagnosis and management of COPD, to potentially improve survival.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Uganda

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Uganda